86 FR 95 pg. 27092 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
Type: NOTICEVolume: 86Number: 95Page: 27092
Page: 27092Docket number: [Docket Nos. FDA-2019-N-5666, FDA-2011-N-0231, FDA-2010-N-0161, FDA-2011-N-0275, and FDA-2013-D-0575]
FR document: [FR Doc. 2021-10535 Filed 5-18-21; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2019-N-5666, FDA-2011-N-0231, FDA-2010-N-0161, FDA-2011-N-0275, and FDA-2013-D-0575]
Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
| Title of collection | OMB control No. | Date approval expires |
|---|---|---|
| Empirical Study of Promotional Implications of Proprietary Prescription Drug Names | 0910-0896 | 4/30/2023 |
| Adverse Experience Reporting for Licensed Biological Products; and General Records | 0910-0308 | 4/30/2024 |
| Export Certificates for FDA Regulated Products | 0910-0498 | 4/30/2024 |
| Certification to Accompany Drug, Biological Product, and Device Applications or Submissions | 0910-0616 | 4/30/2024 |
| Expedited Program for Serious Conditions-Drugs and Biologics | 0910-0765 | 4/30/2024 |
Dated: May 14, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-10535 Filed 5-18-21; 8:45 am]
BILLING CODE 4164-01-P